EFFICACY ANALYSIS BY DISEASE RISK SUBGROUP FOR THE PHASE 3 ATHENA-MONO STUDY (GOG3020/ENGOT-OV45) EVALUATING RUCAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH NEWLY DIAGNOSED OVARIAN CANCER


Creative Commons License

O'Malley D., Christopoulou A., Lim M. C., Diaz J., DEMİRKIRAN F., Wilson M., ...Daha Fazla

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022 (SCI-Expanded, Scopus) identifier